BioSpace News Archive

Biovica, active in blood-based cancer monitoring, announces that a clinical trial, BettER, is being launched at Washington University School of Medicine in St. Louis.

Pfizer Inc. announced that the European Commission has granted marketing authorization for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age.

Ryvu Therapeutics, a clinical-stage drug discovery and development company focusing on novel small-molecule therapies that address emerging targets in oncology, summarizes its 2023 fiscal year and provides a corporate update.

Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024.

Antheia and Olon Group announced an ongoing partnership to leverage Olon’s vast fermentation infrastructure to manufacture Antheia’s early products.

Greenwich LifeSciences, Inc. announced that its Board of Directors has extended the lock-up of the shares owned by the Company’s directors, officers, and existing pre-IPO investors to June 30, 2025 which is approximately 57 months from date of the Company’s IPO.

AbTherx, Inc. and Single Cell Technology, Inc. announced that AbTherx selected Single Cell for its first antibody discovery campaigns.

Caris Life Sciences®, announced that the company and collaborators within the Caris Precision Oncology Alliance™ will collectively present three studies across multiple gynecological tumor types at the 2024 SGO Annual Meeting on Women’s Cancer, March 16-18, 2024, in San Diego.

Ricoh Company, Ltd. announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited for access to the foundational CRISPR/Cas9 genome editing technology patents managed by ERS Genomics.

FluoGuide A/S announces that Ole Larsen has bought shares.